• Rotavirus Suppresses Nrf2-Dependent Antioxidant Defense: New

  2026-08-04

  This study demonstrates that progressive rotavirus infection robustly downregulates the redox-sensitive transcription factor Nrf2 and its downstream antioxidant genes in vitro. The findings reveal novel mechanisms by which rotavirus evades host cellular stress responses, with broader implications for antiviral strategy development and redox biology.

• Stable Isotope-Diluted UHPLC-MS/MS for Methylated Purine Qua

  2026-08-04

  This study introduces a highly sensitive, stable isotope-diluted UHPLC–MS/MS method for accurate quantification of methylated purine nucleosides, including 1-methyl Adenosine, in cells. The approach significantly enhances detection sensitivity, resolving isomers and enabling robust intracellular quantification, with implications for biomarker discovery and RNA modification research.

• Cytoskeleton Control of Mechanical Stress-Induced Autophagy

  2026-08-03

  This study demonstrates that the cytoskeleton, especially microfilaments, is essential for autophagy triggered by mechanical stress in human cells. The findings clarify how cytoskeletal integrity mediates mechanotransduction, offering new insights for dissecting calcium signaling pathways and cellular homeostasis.

• Troglitazone as a PPARγ Agonist: Applied Workflows & TAM Inn

  2026-08-03

  Troglitazone, a potent PPARγ agonist, uniquely bridges metabolic and tumor microenvironment research. Its dual action enables precise modulation of lipid/glucose homeostasis and anti-tumor strategies targeting TAM, making it a cornerstone for advanced translational studies.

• Mutational Landscape in Myeloma Cell Lines: Pathways and Dru

  2026-08-02

  This study provides the first exome-wide characterization of mutations across human multiple myeloma cell lines, revealing key driver genes and pathways linked to tumor progression and resistance. The findings enable more precise model selection and pathway dissection for future therapeutic research.

• Strategic SAHH Inhibition: Unraveling Fibrosis via Methylati

  2026-08-01

  This thought-leadership article explores the strategic application of 3-Deazaadenosine hydrochloride, a selective S-adenosylhomocysteine hydrolase inhibitor, for translational researchers investigating hepatic stellate cell activation and liver fibrosis. By integrating mechanistic insight into m6A methylation—specifically the IGF2BP1/TUBB4B/FAK axis—with practical protocol guidance and competitive analysis, this article positions APExBIO’s high-purity reagent as a pivotal tool in the next generation of methylation-driven disease research.

• Exendin-4 (Exenatide): Applied Workflows for Diabetes Resear

  2026-07-31

  Exendin-4 (Exenatide) is transforming type 2 diabetes research with robust models for insulin sensitivity improvement and hepatic steatosis reversal. Discover actionable protocols, troubleshooting strategies, and insights from the latest recombinant production breakthroughs, all powered by APExBIO’s trusted reagent quality.

• Palbociclib (PD0332991) Isethionate: Reliable CDK4/6 Inhibit

  2026-07-31

  This article addresses key laboratory challenges when using Palbociclib (PD0332991) Isethionate (SKU A8335) for cell cycle, viability, and apoptosis assays. Drawing on recent literature and rigorous product data, we provide scenario-driven guidance for optimizing experimental design, interpreting results, and selecting reliable suppliers. Researchers will find actionable solutions for reproducible, data-backed studies involving CDK4/6 inhibition.

• Dorsomorphin (Compound C): Precision AMPK and BMP Pathway Co

  2026-07-30

  Dorsomorphin (Compound C) stands out for its dual inhibition of AMPK and BMP/Smad signaling, enabling precise dissection of metabolic and differentiation pathways in cell and animal models. This guide delivers practical workflows, troubleshooting strategies, and cross-domain insights to maximize experimental reproducibility with APExBIO’s trusted reagent.

• Partial BACE1 Inhibition Reduces Amyloid-β Without Synaptic

  2026-07-30

  Satir et al. (2020) demonstrated that partial inhibition of BACE1, the enzyme initiating amyloid-β (Aβ) production, can reduce Aβ secretion by up to 50% without impairing synaptic transmission in neuronal cultures. This finding informs Alzheimer’s disease research by supporting moderate BACE1 inhibition as a synaptic-sparing therapeutic strategy.

• 10074-G5: Advancing c-Myc Inhibitor Science Beyond Assays

  2026-07-29

  Explore the mechanistic and translational depth of 10074-G5 as a c-Myc inhibitor. This article reveals new scientific insights for cancer research, distinguishing itself from standard assay guides.

• GW 6471: Precision PPARα Antagonist in Hepatotoxicity Models

  2026-07-29

  GW 6471 is a selective PPARα antagonist that empowers researchers to dissect the molecular mechanisms of hepatotoxicity and metabolic disruption, especially in advanced zebrafish and cellular workflows. Its robust performance and specificity, supplied by APExBIO, make it a cornerstone for lipid homeostasis and environmental toxicology studies.

• DAMGO: Precision µ-Opioid Receptor Agonist in Pain Research

  2026-07-28

  DAMGO stands out as a highly selective µ-opioid receptor agonist, enabling targeted dissection of opioid signaling and pain pathways. Recent studies reveal its unique ability to model and unravel paradoxical opioid-induced hypersensitivity, revolutionizing chronic pain research and experimental assay design.

• Metronidazole for Research: OAT3 Inhibition & Microbial Mode

  2026-07-28

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) stands out as a dual-function research tool: it enables precise OAT3 inhibition and robust antimicrobial assays. This article unpacks how APExBIO’s high-purity Metronidazole streamlines drug-drug interaction studies and microbiome-mimetic workflows, with practical troubleshooting and protocol guidance.

• Evaluating Keratinocyte Models for NLRP1 Inflammasome Resear

  2026-07-27

  This study systematically compares primary and immortalized human keratinocyte cell lines for their suitability in NLRP1 inflammasome activation assays. The findings highlight the critical importance of model selection in inflammasome research and advise using primary keratinocytes for reliable detection of NLRP1-mediated responses to inducers such as UVB and talabostat.

11748 records 1/784 page Next 12345 下5页 Last page